Eisai Co. Ltd.'s Fiscal Year is From April To March.
The item "Enterprise-Value-To-Ebitda-Ratio" stands at 12.25 as of 09/30/2025.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Enterprise Value To Ebitda Ratio" stands at 12.25. This represents an increase of 33.44 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -15.00 percent compared to the value the year prior.
The 1 year change in percent is -15.00.
The 3 year change in percent is -72.02.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Enterprise Value To Ebitda Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Enterprise Value To Ebitda Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Enterprise Value To Ebitda Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Enterprise Value To Ebitda Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Enterprise Value To Ebitda Ratio | 280,205,508,085.11 |